Spots Global Cancer Trial Database for childhood acute lymphoblastic leukemia
Every month we try and update this database with for childhood acute lymphoblastic leukemia cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Poly(Ethylene Glycol)(PEG)-Asparaginase During Two Treatment Courses | NCT00192673 | Acute Lymphobla... | PEG-asparaginas... | 1 Year - 14 Years | Nordic Society for Pediatric Hematology and Oncology | |
| Study of the Physical and Emotional Needs of Parents Caring for Children Receiving Chemotherapy for Acute Lymphoblastic Leukemia | NCT00056069 | Leukemia | questionnaire a... | - | Children's Oncology Group | |
| Childhood Acute Lymphoblastic Leukemia Treatment Protocol Moscow-Berlin 2008 | NCT01953770 | Childhood Acute... | PEG-L-asparagin... PEG-L-asparagin... E.coli L-aspara... High-dose Metho... Low-dose Methot... Triple intrathe... Cranial irradia... Daunorubicin | 1 Year - 18 Years | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | |
| Laser Therapy Effect on Oral Mucositis in Childhood Acute Lymphoblastic Leukemia Patients | NCT05452668 | Oral Mucositis Childhood Acute... | Laser Therapy Sham procedure | 3 Years - 14 Years | Children's Cancer Hospital Egypt 57357 | |
| Liposomal Cytarabine for Central Nervous System (CNS)-Treatment in High-risk Acute Lymphoblastic Leukemia (ALL) | NCT00991744 | Acute Lymphobla... | Liposomal cytar... Intrathecal tri... | 1 Year - 18 Years | Nordic Society for Pediatric Hematology and Oncology | |
| Kidney Dysfunction in Children and Young Adults Who Have Received Methotrexate for Acute Lymphoblastic Leukemia | NCT00993135 | Leukemia Renal Toxicity | methotrexate medical chart r... assessment of t... | - 21 Years | Vanderbilt University Medical Center | |
| Sirolimus, Cyclosporine, and Mycophenolate Mofetil in Preventing Graft-versus-Host Disease in Treating Patients With Blood Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant | NCT01251575 | Adult Acute Lym... Adult Acute Mye... Adult Diffuse L... Adult Myelodysp... Adult Non-Hodgk... Aggressive Non-... Childhood Acute... Childhood Acute... Childhood Diffu... Childhood Myelo... Childhood Non-H... Chronic Lymphoc... Chronic Lymphoc... Chronic Phase C... Hematopoietic a... Mantle Cell Lym... Plasma Cell Mye... Prolymphocytic ... Recurrent Chron... Refractory Chro... T-Cell Prolymph... Waldenstrom Mac... Recurrent Diffu... Recurrent Hodgk... | Allogeneic Hema... Cyclosporine Fludarabine Pho... Laboratory Biom... Mycophenolate M... Peripheral Bloo... Sirolimus Total-Body Irra... | - | Fred Hutchinson Cancer Center | |
| Acute Lymphoblastic Leukemia Treatment Protocol Moscow-Berlin 2019 Pilot | NCT04723342 | Childhood Acute... | Blinatumomab | 1 Year - 18 Years | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | |
| Unravelling the Role of KCTD Protein Family in the Clinical Management of Childhood Acute Lymphoblastic Leukemias | NCT05729178 | Childhood Acute... | observational s... | 1 Year - 18 Years | IRCCS SYNLAB SDN | |
| Sirolimus, Cyclosporine, and Mycophenolate Mofetil in Preventing Graft-versus-Host Disease in Treating Patients With Blood Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant | NCT01251575 | Adult Acute Lym... Adult Acute Mye... Adult Diffuse L... Adult Myelodysp... Adult Non-Hodgk... Aggressive Non-... Childhood Acute... Childhood Acute... Childhood Diffu... Childhood Myelo... Childhood Non-H... Chronic Lymphoc... Chronic Lymphoc... Chronic Phase C... Hematopoietic a... Mantle Cell Lym... Plasma Cell Mye... Prolymphocytic ... Recurrent Chron... Refractory Chro... T-Cell Prolymph... Waldenstrom Mac... Recurrent Diffu... Recurrent Hodgk... | Allogeneic Hema... Cyclosporine Fludarabine Pho... Laboratory Biom... Mycophenolate M... Peripheral Bloo... Sirolimus Total-Body Irra... | - | Fred Hutchinson Cancer Center | |
| Kidney Dysfunction in Children and Young Adults Who Have Received Methotrexate for Acute Lymphoblastic Leukemia | NCT00993135 | Leukemia Renal Toxicity | methotrexate medical chart r... assessment of t... | - 21 Years | Vanderbilt University Medical Center | |
| Childhood Acute Lymphoblastic Leukemia Treatment Protocol Moscow-Berlin 2015 (ALL-MB 2015) | NCT03390387 | Childhood Acute... | Dexamethasone c... Dexamethasone i... Dexamethasone Methylprednisol... Daunorubicin Idarubicin Bortezomib Second phase of... Standard induct... Standard consol... | 1 Year - 50 Years | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | |
| Identifying Risk Factors for Bone Tissue Death in Young Patients With Acute Lymphoblastic Leukemia Treated on Clinical Trial CCG-1882 | NCT00898469 | Leukemia | polymorphism an... | 10 Years - 120 Months | Children's Oncology Group | |
| Acute Lymphoblastic Leukemia Treatment Protocol Moscow-Berlin 2019 Pilot | NCT04723342 | Childhood Acute... | Blinatumomab | 1 Year - 18 Years | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | |
| Study of the Physical and Emotional Needs of Parents Caring for Children Receiving Chemotherapy for Acute Lymphoblastic Leukemia | NCT00056069 | Leukemia | questionnaire a... | - | Children's Oncology Group | |
| Goal Management Training for Adult Survivors of Childhood Leukemia and Non-Hodgkins Lymphoma With Neurocognitive Sequelae | NCT04541056 | Childhood Non-H... Childhood Acute... Childhood Acute... | Goal Management... Brain Health Wo... | 18 Years - 40 Years | Norwegian University of Science and Technology | |
| Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer | NCT00898079 | Acute Undiffere... Atypical Chroni... Childhood Acute... Childhood Acute... Childhood Chron... Childhood Solid... Chronic Lymphoc... Hairy Cell Leuk... Juvenile Myelom... Mast Cell Leuke... Neoplasm of Unc... Prolymphocytic ... Secondary Acute... T-Cell Large Gr... | Cytology Specim... | - 30 Years | Children's Oncology Group | |
| ALL2008 Protocol for Childhood Acute Lymphoblastic Leukemia Intermittent Versus Continuous PEG Asparaginase | NCT00819351 | Acute Lymphobla... | PEG Asparaginas... PEG Asparaginas... | 1 Year - 45 Years | Rigshospitalet, Denmark | |
| Erwinia Asparaginase After Allergy to PEG-Asparaginase in Treating Young Patients With Acute Lymphoblastic Leukemia | NCT00537030 | Adult Acute Lym... Childhood Acute... | Asparaginase Laboratory Biom... Pharmacological... | 1 Year - 30 Years | Children's Oncology Group | |
| ALL2008 Protocol for Childhood Acute Lymphoblastic Leukemia (ALL) - 6MP Consolidation Therapy | NCT00816049 | Acute Lymphobla... | 6MPindividualiz... 6MPfixed | 1 Year - 45 Years | Rigshospitalet, Denmark | |
| CAR-T for Children With Relapsed and Refractory Acute Lymphoblastic Leukemia | NCT04626765 | Childhood Acute... | CD19 CAR-T CD22 CAR-T CD 19+22 Fludarabine Cyclophosphamid... | 1 Year - 18 Years | Hebei Senlang Biotechnology Inc., Ltd. | |
| Osteoporosis in Children With ALL | NCT00330538 | Leukemia, Lymph... | 4 Years - 18 Years | Children's Mercy Hospital Kansas City | ||
| An Open-Label Study of JZP-458 (RC-P) in Patients With Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL) | NCT04145531 | Acute Lymphobla... Lymphoblastic L... | IM JZP-458 IV JZP-458 | - | Jazz Pharmaceuticals | |
| ALL2008 Protocol for Childhood Acute Lymphoblastic Leukemia (ALL) - 6MP Consolidation Therapy | NCT00816049 | Acute Lymphobla... | 6MPindividualiz... 6MPfixed | 1 Year - 45 Years | Rigshospitalet, Denmark | |
| Treatment Protocol of Children With Philadelphia Chromosome Negative High Risk Acute Lymphoblastic Leukemia | NCT01990807 | Childhood Acute... Philadelphia Ch... B-cell Childhoo... | Idarubicin(IDA) | 6 Months - 18 Years | ChineseAMS | |
| Erwinia Asparaginase After Allergy to PEG-Asparaginase in Treating Young Patients With Acute Lymphoblastic Leukemia | NCT00537030 | Adult Acute Lym... Childhood Acute... | Asparaginase Laboratory Biom... Pharmacological... | 1 Year - 30 Years | Children's Oncology Group | |
| Erwinia Asparaginase After Allergy to PEG-Asparaginase in Treating Young Patients With Acute Lymphoblastic Leukemia | NCT00537030 | Adult Acute Lym... Childhood Acute... | Asparaginase Laboratory Biom... Pharmacological... | 1 Year - 30 Years | Children's Oncology Group | |
| Study of the Physical and Emotional Needs of Parents Caring for Children Receiving Chemotherapy for Acute Lymphoblastic Leukemia | NCT00056069 | Leukemia | questionnaire a... | - | Children's Oncology Group | |
| Silymarin (Milk Thistle Extract) in Treating Patients With Acute Lymphoblastic Leukemia Who Are Receiving Chemotherapy | NCT00055718 | Drug/Agent Toxi... Leukemia | silymarin | 2 Years - 21 Years | National Cancer Institute (NCI) | |
| Osteoporosis in Children With ALL | NCT00330538 | Leukemia, Lymph... | 4 Years - 18 Years | Children's Mercy Hospital Kansas City |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
